MRNA
Moderna Inc
Price:  
34.62 
USD
Volume:  
7,699,942.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNA WACC - Weighted Average Cost of Capital

The WACC of Moderna Inc (MRNA) is 8.6%.

The Cost of Equity of Moderna Inc (MRNA) is 8.60%.
The Cost of Debt of Moderna Inc (MRNA) is 6.20%.

Range Selected
Cost of equity 7.60% - 9.60% 8.60%
Tax rate 5.40% - 10.00% 7.70%
Cost of debt 5.40% - 7.00% 6.20%
WACC 7.6% - 9.6% 8.6%
WACC

MRNA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.81 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 9.60%
Tax rate 5.40% 10.00%
Debt/Equity ratio 0 0
Cost of debt 5.40% 7.00%
After-tax WACC 7.6% 9.6%
Selected WACC 8.6%